| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 142, 1339-1346, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
DN Shapiro, MB Valentine, ST Rowe, AE Sinclair, JE Sublett, WM Roberts and AT Look
Department of Experimental Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105.
We assessed fluorescence in situ hybridization (FISH) as an alternative to Southern blot analysis for determination of N-myc gene amplification in neuroblastoma. In the 44 pediatric solid tumor cell lines examined (20 neuroblastomas), the mean number of N-myc copies determined by FISH correlated closely with Southern blot results. There was wide intercellular variability in gene copy number in tumors that had evidence of amplification; however, tumors judged to be non-amplified completely lacked any cells with high N-myc copy number. FISH provided reliable estimates of N-myc amplification in 12 clinical samples even when the percentage of tumor was low. The other advantages of FISH over Southern blot analysis were speed and technical simplicity, ability to discern heterogeneous gene amplification among tumor cells in the same specimen, and capacity to determine the source of the amplified N-myc signal, whether extrachromosomal double-minute chromosomes, expanded intrachromosomal regions, or chromosome 2 aneuploidy. We conclude that FISH would refine the analysis of N-myc amplification in neuroblastoma and thus improve the assignment of patients to prognostic groups based on this unfavorable risk factor.
This article has been cited by other articles:
![]() |
J. Schneiderman, W. B. London, G. M. Brodeur, R. P. Castleberry, A. T. Look, and S. L. Cohn Clinical Significance of MYCN Amplification and Ploidy in Favorable-Stage Neuroblastoma: A Report From the Children's Oncology Group J. Clin. Oncol., February 20, 2008; 26(6): 913 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haber, J. Smith, S. B. Bordow, C. Flemming, S. L. Cohn, W. B. London, G. M. Marshall, and M. D. Norris Association of High-Level MRP1 Expression With Poor Clinical Outcome in a Large Prospective Study of Primary Neuroblastoma J. Clin. Oncol., April 1, 2006; 24(10): 1546 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. George, W. B. London, S. L. Cohn, J. M. Maris, C. Kretschmar, L. Diller, G. M. Brodeur, R. P. Castleberry, and A. T. Look Hyperdiploidy Plus Nonamplified MYCN Confers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study J. Clin. Oncol., September 20, 2005; 23(27): 6466 - 6473. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.B. London, R.P. Castleberry, K.K. Matthay, A.T. Look, R.C. Seeger, H. Shimada, P. Thorner, G. Brodeur, J.M. Maris, C.P. Reynolds, et al. Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group J. Clin. Oncol., September 20, 2005; 23(27): 6459 - 6465. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kretschmar, M. Kletzel, K. Murray, P. Thorner, V. Joshi, R. Marcus, E. I. Smith, W. B. London, and R. Castleberry Response to Paclitaxel, Topotecan, and Topotecan-Cyclophosphamide in Children With Untreated Disseminated Neuroblastoma Treated in an Upfront Phase II Investigational Window: A Pediatric Oncology Group Study J. Clin. Oncol., October 15, 2004; 22(20): 4119 - 4126. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Katzenstein, S. L. Cohn, R. M. Shore, D. M.E. Bardo, P. R. Haut, M. Olszewski, J. Schmoldt, D. Liu, A. W. Rademaker, and M. Kletzel Scintigraphic Response by 123I-Metaiodobenzylguanidine Scan Correlates With Event-Free Survival in High-Risk Neuroblastoma J. Clin. Oncol., October 1, 2004; 22(19): 3909 - 3915. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Cook, A. F. Olshan, H. A. Guess, D. A. Savitz, C. Poole, J. Blatt, M. L. Bondy, and B. H. Pollock Maternal Medication Use and Neuroblastoma in Offspring Am. J. Epidemiol., April 15, 2004; 159(8): 721 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krams, H.-J. Heidebrecht, B. Hero, F. Berthold, D. Harms, R. Parwaresch, and P. Rudolph repp86 Expression and Outcome in Patients With Neuroblastoma J. Clin. Oncol., May 1, 2003; 21(9): 1810 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kletzel, H. M. Katzenstein, P. R. Haut, A. L. Yu, E. Morgan, M. Reynolds, G. Geissler, M. H. Marymount, D. Liu, J. A. Kalapurakal, et al. Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II Study J. Clin. Oncol., May 1, 2002; 20(9): 2284 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Bown Neuroblastoma tumour genetics: clinical and biological aspects J. Clin. Pathol., December 1, 2001; 54(12): 897 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krams, A. Claviez, K. Heidorn, G. Krupp, R. Parwaresch, D. Harms, and P. Rudolph Regulation of Telomerase Activity by Alternate Splicing of Human Telomerase Reverse Transcriptase mRNA in a Subset of Neuroblastomas Am. J. Pathol., November 1, 2001; 159(5): 1925 - 1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. De Roos, A. F. Olshan, K. Teschke, C. Poole, D. A. Savitz, J. Blatt, M. L. Bondy, and B. H. Pollock Parental Occupational Exposures to Chemicals and Incidence of Neuroblastoma in Offspring Am. J. Epidemiol., July 15, 2001; 154(2): 106 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Katzenstein, P. M. Kent, W. B. London, and S. L. Cohn Treatment and Outcome of 83 Children With Intraspinal Neuroblastoma: The Pediatric Oncology Group Experience J. Clin. Oncol., February 15, 2001; 19(4): 1047 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Cohn, W. B. London, D. Huang, H. M. Katzenstein, H. R. Salwen, T. Reinhart, J. Madafiglio, G. M. Marshall, M. D. Norris, and M. Haber MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN J. Clin. Oncol., November 1, 2000; 18(21): 3604 - 3613. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yang, A. F. Olshan, M. L. Bondy, N. R. Shah, B. H. Pollock, R. C. Seeger, A. T. Look, and S. L. Cohn Parental Smoking and Alcohol Consumption and Risk of Neuroblastoma Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 967 - 972. [Abstract] [Full Text] |
||||
![]() |
C. Poremba, C. Scheel, B. Hero, H. Christiansen, K.-L. Schaefer, J.-i. Nakayama, F. Berthold, H. Juergens, W. Boecker, and B. Dockhorn-Dworniczak Telomerase Activity and Telomerase Subunits Gene Expression Patterns in Neuroblastoma: A Molecular and Immunohistochemical Study Establishing Prognostic Tools for Fresh-Frozen and Paraffin-Embedded Tissues J. Clin. Oncol., July 1, 2000; 18(13): 2582 - 2592. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Raggi, M. L. Bagnoni, G. P. Tonini, M. Maggi, G. Vona, P. Pinzani, K. Mazzocco, B. De Bernardi, M. Pazzagli, and C. Orlando Real-Time Quantitative PCR for the Measurement of MYCN Amplification in Human Neuroblastoma with the TaqMan Detection System Clin. Chem., November 1, 1999; 45(11): 1918 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshimoto, S. R. Caminada de Toledo, E. M. Monteiro Caran, M. T. de Seixas, M. L. de Martino Lee, S. de Campos Vieira Abib, S. M. R. Vianna, S. T. Schettini, and J. Anderson Duffles Andrade MYCN Gene Amplification : Identification of Cell Populations Containing Double Minutes andHomogeneously Staining Regions in Neuroblastoma Tumors Am. J. Pathol., November 1, 1999; 155(5): 1439 - 1443. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-F. Chen, M.-L. Chen, D.-C. Liang, H.-C. Liu, and S.-H. Chen The Relationship of N-myc Amplification and Apoptosis in Neuroblastoma International Journal of Surgical Pathology, January 1, 1999; 7(1): 19 - 25. [Abstract] [PDF] |
||||
![]() |
R. Gururajan, J. M. Lahti, J. Grenet, J. Easton, I. Gruber, P. F. Ambros, and V. J. Kidd Duplication of a Genomic Region Containing the Cdc2L1-2 and MMP21-22 Genes on Human Chromosome 1p36.3 and their Linkage to D1Z2 Genome Res., September 1, 1998; 8(9): 929 - 939. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |